BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiboski CH, Patton LL, Webster-Cyriaque JY, Greenspan D, Traboulsi RS, Ghannoum M, Jurevic R, Phelan JA, Reznik D, Greenspan JS. The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpoints. J Oral Pathol Med. 2009;38:481-488. [PMID: 19594839 DOI: 10.1111/j.1600-0714.2009.00749.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 de Almeida VL, Lima IFP, Ziegelmann PK, Paranhos LR, de Matos FR. Impact of highly active antiretroviral therapy on the prevalence of oral lesions in HIV-positive patients: a systematic review and meta-analysis. Int J Oral Maxillofac Surg 2017;46:1497-504. [PMID: 28684301 DOI: 10.1016/j.ijom.2017.06.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Feller L, Khammissa RA, Wood NH, Meyerov R, Pantanowitz L, Lemmer J. Oral ulcers and necrotizing gingivitis in relation to HIV-associated neutropenia: a review and an illustrative case. AIDS Res Hum Retroviruses 2012;28:346-51. [PMID: 21728927 DOI: 10.1089/AID.2011.0141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Patton LL, Ramirez-Amador V, Anaya-Saavedra G, Nittayananta W, Carrozzo M, Ranganathan K. Urban legends series: oral manifestations of HIV infection. Oral Dis. 2013;19:533-550. [PMID: 23517181 DOI: 10.1111/odi.12103] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
4 Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012;62:400-422. [PMID: 22972543 DOI: 10.3322/caac.21157] [Cited by in Crossref: 216] [Cited by in F6Publishing: 157] [Article Influence: 24.0] [Reference Citation Analysis]
5 Ghannoum MA, Mukherjee PK, Jurevic RJ, Retuerto M, Brown RE, Sikaroodi M, Webster-Cyriaque J, Gillevet PM. Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets. OMICS 2013;17:5-15. [PMID: 21751871 DOI: 10.1089/omi.2011.0035] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
6 Lauritano D, Moreo G, Oberti L, Lucchese A, Di Stasio D, Conese M, Carinci F. Oral Manifestations in HIV-Positive Children: A Systematic Review. Pathogens 2020;9:E88. [PMID: 32023908 DOI: 10.3390/pathogens9020088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
7 Nittayananta W, Amornthatree K, Kemapunmanus M, Talungchit S, Sriplung H. Expression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy. Oral Dis 2014;20:e57-64. [PMID: 23718561 DOI: 10.1111/odi.12135] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kuteyi T, Okwundu CI. Topical treatments for HIV-related oral ulcers. Cochrane Database Syst Rev. 2012;1:CD007975. [PMID: 22258979 DOI: 10.1002/14651858.cd007975.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Gonçalves LS, Júnior AS, Ferreira SM, Sousa CO, Fontes TV, Vettore MV, Torres SR. Factors associated with specific clinical forms of oral candidiasis in HIV-infected Brazilian adults. Arch Oral Biol 2013;58:657-63. [PMID: 23123068 DOI: 10.1016/j.archoralbio.2012.10.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mukherjee PK, Chen H, Patton LL, Evans S, Lee A, Kumwenda J, Hakim J, Masheto G, Sawe F, Pho MT, Freedberg KA, Shiboski CH, Ghannoum MA, Salata RA; Oral HIVAIDS Research Alliance (OHARA)AIDS Clinical Trials Group (ACTG) 5265 Team. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. AIDS 2017;31:81-8. [PMID: 27677161 DOI: 10.1097/QAD.0000000000001286] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
11 Gušić I, Medić D, Radovanović Kanjuh M, Ðurić M, Brkić S, Turkulov V, Predin T, Mirnić J. Treatment of Periodontal Disease with an Octenidine-based Antiseptic in HIV-positive Patients. Int J Dent Hyg 2016;14:108-16. [PMID: 25847374 DOI: 10.1111/idh.12141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Nair RG, Salajegheh A, Itthagarun A, Pakneshan S, Brennan MT, Samaranayake LP. Orofacial viral infections--an update for clinicians. Dent Update 2014;41:518-20, 522-4. [PMID: 25195484 DOI: 10.12968/denu.2014.41.6.518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
13 Syrjänen S. Human Papillomavirus Infection and Its Association with HIV. Adv Dent Res 2011;23:84-9. [DOI: 10.1177/0022034511399914] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
14 Castillejos-García I, Ramírez-Amador V, Gómez-Mejía E, Badial-Hernández F, Anaya-Saavedra G. Clinical manifestations and risk factors for oral immune reconstitution inflammatory syndrome in Mexico. Oral Dis 2020;26 Suppl 1:153-7. [PMID: 32862543 DOI: 10.1111/odi.13402] [Reference Citation Analysis]
15 Rovaris NS, Galato D, Schuelter-Trevisol F, da Silva J, Linhar Lda S, Nickel DA, Traebert J. Oral health status and its impact on the quality of life of children and adolescents living with HIV-1. BMC Res Notes 2014;7:478. [PMID: 25069518 DOI: 10.1186/1756-0500-7-478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shiboski CH, Chen H, Secours R, Lee A, Webster-Cyriaque J, Ghannoum M, Evans S, Bernard D, Reznik D, Dittmer DP, Hosey L, Sévère P, Aberg JA; Oral HIV/AIDS Research Alliance, Subcommittee of the AIDS Clinical Trial Group. High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group. PLoS One 2015;10:e0131001. [PMID: 26148192 DOI: 10.1371/journal.pone.0131001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
17 Saxena D, Li Y, Devota A, Pushalkar S, Abrams W, Barber C, Corby P, Poles M, Phelan J, Malamud D. Modulation of the orodigestive tract microbiome in HIV-infected patients. Oral Dis 2016;22 Suppl 1:73-8. [PMID: 27109275 DOI: 10.1111/odi.12392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
18 Nittayananta W, Mitarnun W, Talungchit S, Sriplung H. Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART. Oral Dis 2012;18:793-801. [PMID: 22747944 DOI: 10.1111/j.1601-0825.2012.01947.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
19 Unnewehr M, Sieling C, Schaaf B. [A practically orientated clinical HIV update for ENT physicians]. HNO 2015;63:63-72; quiz 73. [PMID: 25359597 DOI: 10.1007/s00106-014-2937-y] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Almazyad A, Alabdulaaly L, Noonan V, Woo SB. Oral hairy leukoplakia: a series of 45 cases in immunocompetent patients. Oral Surg Oral Med Oral Pathol Oral Radiol 2021;132:210-6. [PMID: 34030995 DOI: 10.1016/j.oooo.2021.03.015] [Reference Citation Analysis]
21 Ellepola AN, Joseph BK, Sundaram DB, Sharma PN. Knowledge and attitudes towards HIV/AIDS amongst Kuwait University dental students. Eur J Dent Educ 2011;15:165-71. [PMID: 21762321 DOI: 10.1111/j.1600-0579.2010.00652.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
22 Shiboski CH, Chen H, Ghannoum MA, Komarow L, Evans S, Mukherjee PK, Isham N, Katzenstein D, Asmelash A, Omozoarhe AE, Gengiah S, Allen R, Tripathy S, Swindells S; AIDS Clinical Trials Group Network and Oral HIV/AIDS Research Alliance. Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253. Int J Tuberc Lung Dis 2014;18:682-8. [PMID: 24903939 DOI: 10.5588/ijtld.13.0729] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
23 Yengopal V, Kolisa Y, Thekiso MD, Molete MP. The child and adolescent with HIV in resource poor countries. Oral Dis 2016;22 Suppl 1:25-34. [PMID: 26879655 DOI: 10.1111/odi.12411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
24 Syebele K, Munzhelele TI. Oral mucocele/ranula: Another human immunodeficiency virus-related salivary gland disease? Laryngoscope 2015;125:1130-6. [PMID: 25446909 DOI: 10.1002/lary.25058] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
25 Phelan JA, Abrams WR, Norman RG, Li Y, Laverty M, Corby PM, Nembhard J, Neri D, Barber CA, Aberg JA, Fisch GS, Poles MA, Malamud D. Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbes. PLoS One 2014;9:e112901. [PMID: 25409430 DOI: 10.1371/journal.pone.0112901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Patton LL. Current strategies for prevention of oral manifestations of human immunodeficiency virus. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;121:29-38. [PMID: 26679357 DOI: 10.1016/j.oooo.2015.09.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
27 Nouaman MN, Meless DG, Coffie PA, Arrivé E, Tchounga BK, Ekouévi DK, Anoma C, Eholié SP, Dabis F, Jaquet A; IeDEA West Africa collaboration. Oral health and HIV infection among female sex workers in Abidjan, Côte d'Ivoire. BMC Oral Health 2015;15:154. [PMID: 26631015 DOI: 10.1186/s12903-015-0129-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
28 Singer R, Cardenas G, Xavier J, Jeanty Y, Pereyra M, Rodriguez A, Metsch LR. Dental anxiety and the use of oral health services among people attending two HIV primary care clinics in Miami. Public Health Rep 2012;127 Suppl 2:36-44. [PMID: 22547875 DOI: 10.1177/00333549121270S206] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Pandiyan P, Younes SA, Ribeiro SP, Talla A, McDonald D, Bhaskaran N, Levine AD, Weinberg A, Sekaly RP. Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation. Front Immunol 2016;7:228. [PMID: 27379092 DOI: 10.3389/fimmu.2016.00228] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
30 Malele Kolisa Y, Yengopal V, Shumba K, Igumbor J. The burden of oral conditions among adolescents living with HIV at a clinic in Johannesburg, South Africa. PLoS One 2019;14:e0222568. [PMID: 31618211 DOI: 10.1371/journal.pone.0222568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Shiboski CH, Webster-Cyriaque JY, Ghannoum M, Greenspan JS, Dittmer D; Oral HIV/AIDS Research Alliance, Subcommittee of the AIDS Clinical Trial Group. Overview of the oral HIV/AIDS Research Alliance Program. Adv Dent Res 2011;23:28-33. [PMID: 21441477 DOI: 10.1177/0022034511399084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
32 Patton L. Progress in understanding oral health and HIV/AIDS. Oral Dis 2014;20:223-5. [DOI: 10.1111/odi.12220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
33 Moscicki AB, Yao TJ, Ryder MI, Russell JS, Dominy SS, Patel K, McKenna M, Van Dyke RB, Seage GR 3rd, Hazra R; Shiboski. The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth. PLoS One 2016;11:e0156459. [PMID: 27299992 DOI: 10.1371/journal.pone.0156459] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
34 Syebele K, Bütow K. Comparative study of the effect of antiretroviral therapy on benign lymphoepithelial cyst of parotid glands and ranulas in HIV-positive patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2011;111:205-10. [DOI: 10.1016/j.tripleo.2010.09.067] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
35 Presti RM, Handley SA, Droit L, Ghannoum M, Jacobson M, Shiboski CH, Webster-Cyriaque J, Brown T, Yin MT, Overton ET. Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status. AIDS 2018;32:1279-87. [PMID: 29851662 DOI: 10.1097/QAD.0000000000001811] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
36 Shiboski CH, Webster-Cyriaque JY, Ghannoum M, Dittmer DP, Greenspan JS; Oral HIV/AIDS Research Alliance, Subcommittee of the AIDS Clinical Trial Group. The Oral HIV/AIDS Research Alliance Program: lessons learned and future directions. Oral Dis 2016;22 Suppl 1:128-34. [PMID: 27109281 DOI: 10.1111/odi.12409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Warnakulasuriya S. Causes of oral cancer--an appraisal of controversies. Br Dent J 2009;207:471-5. [PMID: 19946320 DOI: 10.1038/sj.bdj.2009.1009] [Cited by in Crossref: 134] [Cited by in F6Publishing: 110] [Article Influence: 12.2] [Reference Citation Analysis]
38 Owotade FJ, Patel M. Virulence of oral Candida isolated from HIV-positive women with oral candidiasis and asymptomatic carriers. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:455-60. [PMID: 25201119 DOI: 10.1016/j.oooo.2014.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
39 Ranganathan K, Umadevi KMR. Common oral opportunistic infections in Human Immunodeficiency Virus infection/Acquired Immunodeficiency Syndrome: Changing epidemiology; diagnostic criteria and methods; management protocols. Periodontol 2000 2019;80:177-88. [PMID: 31090147 DOI: 10.1111/prd.12274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Malamud D. Saliva as a diagnostic fluid. Dent Clin North Am 2011;55:159-78. [PMID: 21094724 DOI: 10.1016/j.cden.2010.08.004] [Cited by in Crossref: 201] [Cited by in F6Publishing: 146] [Article Influence: 20.1] [Reference Citation Analysis]
41 Syebele K, Bütow K, Webber L, Manda SO. Quantification of HIV-1 viral load in the fluid of ranulas in HIV-positive patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2011;111:715-9. [DOI: 10.1016/j.tripleo.2011.01.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
42 Meless D, Ba B, Faye M, Diby JS, N'zoré S, Datté S, Diecket L, N'Diaye C, Aka EA, Kouakou K, Ba A, Ekouévi DK, Dabis F, Shiboski C, Arrivé E. Oral lesions among HIV-infected children on antiretroviral treatment in West Africa. Trop Med Int Health 2014;19:246-55. [PMID: 24386972 DOI: 10.1111/tmi.12253] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
43 Patton LL. Oral Lesions Associated with Human Immunodeficiency Virus Disease. Dental Clinics of North America 2013;57:673-98. [DOI: 10.1016/j.cden.2013.07.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
44 Saxena D, Li Y, Yang L, Pei Z, Poles M, Abrams WR, Malamud D. Human microbiome and HIV/AIDS. Curr HIV/AIDS Rep 2012;9:44-51. [PMID: 22193889 DOI: 10.1007/s11904-011-0103-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
45 Sharma G, Oberoi SS, Vohra P, Nagpal A. Oral manifestations of HIV/AIDS in Asia: Systematic review and future research guidelines. J Clin Exp Dent 2015;7:e419-27. [PMID: 26330942 DOI: 10.4317/jced.52127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
46 Tappuni A. Immune Reconstitution Inflammatory Syndrome. Adv Dent Res 2011;23:90-6. [DOI: 10.1177/0022034511399915] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
47 Balaji TM, Varadarajan S, Sujatha G, Muruganandhan J, Shanmugapriya R, Raj AT, Patil S, Fageeh HI, Fageeh HN, Malik NH, Awan KH. Necrotizing periodontal diseases in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: A review. Dis Mon 2021;67:101168. [PMID: 33640175 DOI: 10.1016/j.disamonth.2021.101168] [Reference Citation Analysis]
48 Blignaut E, Rossouw TM, Becker PJ, Mavuso DS, Feucht UD. Gingival Recession and Localized Aggressive Periodontitis Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy. Pediatr Infect Dis J 2019;38:e112-5. [PMID: 30096098 DOI: 10.1097/INF.0000000000002166] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Portela M, Kneipp L, Ribeiro de Souza I, Holandino C, Alviano C, Meyer-fernandes J, De Araújo Soares R. Ectophosphatase activity in Candida albicans influences fungal adhesion: study between HIV-positive and HIV-negative isolates: Ectophosphatase in Candida albicans. Oral Diseases 2010;16:431-7. [DOI: 10.1111/j.1601-0825.2009.01644.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
50 Elizondo JE, Rocha-Pizaña MD, Treviño AC, Violant D, Álvarez MM, Rivas-Estilla AM. Potential gingival crevicular fluid and serum biomarkers by stage of HIV infection. Cytokine 2017;91:96-103. [PMID: 28043030 DOI: 10.1016/j.cyto.2016.12.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
51 Padovese V, Racalbuto V, Barnabas GA, Morrone A. Operational research on the correlation between skin diseases and HIV infection in Tigray region, Ethiopia. Int J Dermatol 2015;54:1169-74. [PMID: 26394603 DOI: 10.1111/ijd.12809] [Reference Citation Analysis]
52 Palmason S, Marty FM, Treister NS. How Do We Manage Oral Infections in Allogeneic Stem Cell Transplantation and Other Severely Immunocompromised Patients? Oral and Maxillofacial Surgery Clinics of North America 2011;23:579-99. [DOI: 10.1016/j.coms.2011.07.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
53 Nittayananta W, Kemapunmanus M, Yangngam S, Talungchit S, Sriplung H. Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy. J Oral Pathol Med 2013;42:208-15. [PMID: 23126266 DOI: 10.1111/jop.12023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
54 Batavia AS, Secours R, Espinosa P, Jean Juste MA, Severe P, Pape JW, Fitzgerald DW. Diagnosis of HIV-Associated Oral Lesions in Relation to Early versus Delayed Antiretroviral Therapy: Results from the CIPRA HT001 Trial. PLoS One 2016;11:e0150656. [PMID: 26930571 DOI: 10.1371/journal.pone.0150656] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
55 Tejani S, Sultan A, Stojanov I, Woo S. Candidal carriage predicts candidiasis during topical immunosuppressive therapy: a preliminary retrospective cohort study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2016;122:448-54. [DOI: 10.1016/j.oooo.2016.06.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]